Meet us at the 2018 Bio Convention to be held in Boston
17 June 2018
PRESS RELEASE – IL-17 patent granted in Europe
27 October 2018AstraZeneca and Innate Pharma enter into partnership for the development of CD39 mAbs
On October 23, 2018, Innate Pharma announced that it had entered into a development collaboration and option for further co-development and co-commercialisation with AstraZeneca for its CD39 monoclonal antibody, IPH5201.